TY - JOUR
KW - 3363:Medical Treatment of Physical Illness
KW - Adulthood (18 yrs & older)
KW - article
KW - buprenorphine
KW - Death and Dying
KW - Drug Dependency
KW - Drug History Questionnaire
KW - Drug Therapy
KW - Empirical Study
KW - Female
KW - Human
KW - interim treatment
KW - Male
KW - Morbidity
KW - Opiates
KW - opioid abuse
KW - Quantitative Study
KW - Technology
KW - Treatment Effectiveness Evaluation
KW - US
AU - Stacey C. Sigmon
AU - Andrew C. Meyer
AU - Bryce Hruska
AU - Taylor Ochalek
AU - Gail Rose
AU - Gary J. Badger
AU - John R. Brooklyn
AU - Sarah H. Heil
AU - Stephen T. Higgins
AU - Brent A. Moore
AU - Robert P. Schwartz
A1 - 
BT - Addictive Behaviors
C5 - Opioids & Substance Use
JF - Addictive Behaviors
PB - Elsevier Science
PY - 2015
SN - 0306-4603, 0306-4603
SP - 136
EP - 142
EP - 
T1 - Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility.
T2 - Addictive Behaviors
TI - Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility.
U1 - Opioids & Substance Use
VL - 51
VO - 0306-4603, 0306-4603
Y1 - 2015
ER -